TARSUS PHARMACEUTICALS INC. - COMMON STOCK

Tarsus to Report Fourth Quarter and Full Year 2023 Financial Results on Tuesday, February 27, 2024

20 Feb 2024 16:00:00 By Nasdaq GlobeNewswire

Tarsus to Participate in Fireside Chat at the Sixth Annual Guggenheim Healthcare Talks Conference

31 Jan 2024 16:00:00 By Nasdaq GlobeNewswire

Tarsus Announces Positive Topline Results from the Ersa Phase 2a Clinical Trial Evaluating TP-03 for the Treatment of Meibomian Gland Disease in Patients with Demodex Mites

11 Dec 2023 07:00:00 By Nasdaq GlobeNewswire

Tarsus Reports Third Quarter 2023 Financial Results and Recent Business Achievements

09 Nov 2023 15:05:01 By Nasdaq GlobeNewswire

Tarsus to Report Third Quarter 2023 Financial Results on Thursday, November 9, 2023

01 Nov 2023 17:35:08 By Nasdaq GlobeNewswire

Tarsus to Ring Nasdaq Stock Market Closing Bell in Celebration of the Launch of XDEMVY™, the First and Only FDA Approved Treatment for Demodex Blepharitis

06 Sep 2023 07:00:00 By Nasdaq GlobeNewswire

Tarsus to Present at Upcoming Investor Conferences

30 Aug 2023 15:30:00 By Nasdaq GlobeNewswire

Now Available – XDEMVY™ (lotilaner ophthalmic solution) 0.25%, the First and Only FDA Approved Treatment for Demodex Blepharitis

24 Aug 2023 08:00:00 By Nasdaq GlobeNewswire

Tarsus Reports Second Quarter 2023 Financial Results and Recent Business Achievements

10 Aug 2023 15:05:00 By Nasdaq GlobeNewswire

Tarsus Announces Pricing of $100.0 Million Underwritten Public Offering of Common Stock

01 Aug 2023 21:30:33 By Nasdaq GlobeNewswire

Tarsus Announces Proposed $100.0 Million Underwritten Public Offering of Shares of its Common Stock

31 Jul 2023 15:29:44 By Nasdaq GlobeNewswire

Tarsus to Host Virtual Investor Webcast Highlighting the Commercialization Strategy, Plans and Progress for TP-03, Its Potential Treatment for Demodex Blepharitis

12 Jun 2023 07:30:00 By Nasdaq GlobeNewswire

Tarsus to Present at the Jefferies Global Healthcare Conference

05 Jun 2023 07:30:00 By Nasdaq GlobeNewswire

Tarsus Reports First Quarter 2023 Financial Results and Recent Business Achievements

09 May 2023 15:05:02 By Nasdaq GlobeNewswire

Tarsus Launches “Don’t Freak Out. Get Checked Out.” Campaign During Healthy Vision Month to Encourage Patients with Demodex Blepharitis to Visit Eye Care Providers

08 May 2023 07:30:00 By Nasdaq GlobeNewswire

Tarsus to Participate at the Bank of America 2023 Healthcare Conference

03 May 2023 15:30:00 By Nasdaq GlobeNewswire

Tarsus Appoints Jeff Farrow as Chief Financial Officer and Chief Strategy Officer

24 Apr 2023 07:30:00 By Nasdaq GlobeNewswire

Tarsus Reports Full-Year 2022 Financial Results and Recent Business Achievements

13 Mar 2023 15:05:00 By Nasdaq GlobeNewswire

Tarsus to Present at Upcoming Investor Conferences

02 Mar 2023 15:30:00 By Nasdaq GlobeNewswire

Tarsus Added to NASDAQ Biotechnology Index

16 Dec 2022 06:00:00 By Nasdaq GlobeNewswire